glp-1 and perimenopause Let's talk about medications in the context of menopause, because this is where the conversation most often gets flattened into something it is not. This is not about vanity GLP-1 Microdosing for Perimenopause and
Description
C., Kashkouli, A

The analysis revealed that variants in the 'GLP1R' gene, which codes for the GLP-1 receptor, were associated with the drug's effectiveness
These pieces of data collectively indicate that GIPR agonism, either alone or in combination with other weight-lowering agents, can drive significant metabolic benefits

Study identifies benefits, risks linked to popular weight-loss drugs (news release)
